Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 Warren Buffett Stocks to Buy After Berkshire’s Annual Meeting

By Chris Lau, InvestorPlace Contributor

The energy hedge from Occidental is most compelling for Buffett fans, followed by companies buying back shares aggressively.

7 Retirement Stocks for Steady Long-Term Income Growth

By Chris Lau, InvestorPlace Contributor

Investors looking for retirement stocks should look for companies with high growth and steady income and shun risky, unproven stocks.

Avoid UiPath Stock Until It Gets Back on the Right Trail

By Chris Lau, InvestorPlace Contributor

Nasdaq’s bear market is pummeling UiPath’s stock performance that investors should consider Microsoft or the index instead.

Wait Until June before Buying Snowflake Stock

By Chris Lau, InvestorPlace Contributor

Snowflake is entrenching itself at the center of digital transformation in industries like retail and government.

7 Sold-Off Stocks Ready to Surge From Here

By Chris Lau, InvestorPlace Contributor

These stocks fell enough after investors gave up, creating a tremendous buying chance for patient investors.

Load More